FILLMED® M-HA 18

Product Overview: FILLMED® M-HA 18

FILLMED® M-HA 18 is a CE-marked, sterile, transparent, and viscoelastic solution. It is formulated with a high concentration of free (non-crosslinked) hyaluronic acid (18mg/ml) and glycerol (20mg/ml). Produced by Fillmed Laboratoires (formerly Filorga Laboratoires), this product is specifically designed for superficial intradermal injections to address fine lines, improve skin hydration, enhance radiance, and restore skin elasticity.

It is indicated for the treatment of fine wrinkles (e.g., perioral lines, crow’s feet), rehydration of dry or dehydrated skin, and improvement of overall skin quality and density, particularly for skin showing early signs of aging.

Note: This skin revitalization product should only be administered by qualified healthcare professionals trained in superficial injection techniques.

Mechanism of Action and Properties

FILLMED® M-HA 18 delivers its effects through the synergistic action of its two main components:

• Hyaluronic Acid (18mg/ml): The non-crosslinked HA provides immediate and intensive hydration by attracting and binding water molecules within the superficial dermis. This helps to plump out fine lines, improve skin turgor, and create a more favorable environment for cellular activity.
• Glycerol (20mg/ml): A well-known humectant and moisturizing agent, glycerol enhances the hydrating effect of hyaluronic acid. It also contributes to skin barrier function and may help stabilize the HA, potentially prolonging its local effects and providing antioxidant benefits.

This combination aims to redensify skin tissues, improve hydration levels, smooth fine lines, and restore a youthful radiance and elasticity to the skin, without providing significant volume augmentation associated with cross-linked fillers.

Indications and Treatment Protocol

FILLMED® M-HA 18 is indicated for individuals seeking to address:

• Fine lines and superficial wrinkles (e.g., crow’s feet, perioral lines, fine forehead lines)
• Dehydrated or dry skin
• Loss of skin elasticity and firmness
• Dull or tired-looking complexion
• Improvement of skin texture and density

Common treatment areas include the face, neck, décolleté, and hands. A typical treatment protocol usually involves an initial series of 3 sessions spaced approximately 1 month apart, followed by maintenance sessions every 4-6 months, as determined by the practitioner based on skin condition and desired outcomes.

Administration is performed via microinjections into the superficial dermis.

Expected Outcomes

Following a recommended treatment course, anticipated outcomes include:

• Significant improvement in skin hydration and suppleness
• Softening and reduction of fine lines and superficial wrinkles
• Enhanced skin radiance, tone, and a brighter complexion
• Increased skin elasticity and density
• A generally rejuvenated and healthier skin appearance

Potential Adverse Events

As with any superficial injection procedure, patients may experience temporary reactions primarily related to the injections. Practitioners should advise patients on potential side effects:

• Common Reactions (Typically Mild and Transient): Small punctate marks, erythema (redness), mild swelling or bruising (hematomas) at injection points, slight itching, burning sensation, or tenderness. These generally resolve within a few hours to a few days.
• Less Common/Rare Reactions: Persistent irritation, inflammation, infection (if aseptic techniques are not strictly followed), allergic/hypersensitivity reactions (to HA or glycerol, though rare), skin discoloration, nodule formation (granuloma – very rare with non-crosslinked HA).

Patients should be instructed to report any persistent, severe, or concerning reactions to their practitioner promptly.

Storage Conditions

Store according to manufacturer’s recommendations, typically between 2°C and 25°C, protected from light and freezing. Ensure the vial or syringe integrity before use. Once opened, use immediately and discard any unused portion.

Disclaimer: This overview provides general information. Healthcare professionals must consult the full instructions provided with FILLMED® M-HA 18 before administration for comprehensive details regarding product composition, indications, contraindications, warnings, precautions, administration techniques, and potential adverse events.